167 related articles for article (PubMed ID: 18535592)
1. Comparative study of Botox injection treatment for upper eyelid retraction with 6-month follow-up in patients with thyroid eye disease in the congestive or fibrotic stage.
Costa PG; Saraiva FP; Pereira IC; Monteiro ML; Matayoshi S
Eye (Lond); 2009 Apr; 23(4):767-73. PubMed ID: 18535592
[TBL] [Abstract][Full Text] [Related]
2. Transcutaneous dysport injection for treatment of upper eyelid retraction associated with thyroid eye disease.
Salour H; Bagheri B; Aletaha M; Babsharif B; Kleshadi M; Abrishami M; Bagheri A
Orbit; 2010 Apr; 29(2):114-8. PubMed ID: 20394553
[TBL] [Abstract][Full Text] [Related]
3. A review of surgical techniques to correct upper eyelid retraction associated with thyroid eye disease.
Kazim M; Gold KG
Curr Opin Ophthalmol; 2011 Sep; 22(5):391-3. PubMed ID: 21730842
[TBL] [Abstract][Full Text] [Related]
4. A single transcutaneous injection with Botox for dysthyroid lid retraction.
Shih MJ; Liao SL; Lu HY
Eye (Lond); 2004 May; 18(5):466-9. PubMed ID: 15131675
[TBL] [Abstract][Full Text] [Related]
5. Subconjunctival injection of triamcinolone for the treatment of upper lid retraction associated with thyroid eye disease.
Lee JM; Lee H; Park M; Baek S
J Craniofac Surg; 2012 Nov; 23(6):1755-8. PubMed ID: 23147303
[TBL] [Abstract][Full Text] [Related]
6. Botulinum toxin treatment for upper lid retraction of dysthyroidism.
Chuenkongkaew W
J Med Assoc Thai; 2003 Nov; 86(11):1051-4. PubMed ID: 14696787
[TBL] [Abstract][Full Text] [Related]
7. Subconjunctival injection of triamcinolone in the treatment of lid retraction of patients with thyroid eye disease: a case series.
Chee E; Chee SP
Eye (Lond); 2008 Feb; 22(2):311-5. PubMed ID: 17917686
[TBL] [Abstract][Full Text] [Related]
8. Thyroid associated ophthalmopathy: botulinum toxin A in the treatment of upper eyelid retraction--a pilot study.
Träisk F; Tallstedt L
Acta Ophthalmol Scand; 2001 Dec; 79(6):585-8. PubMed ID: 11782224
[TBL] [Abstract][Full Text] [Related]
9. [Morphometric analysis of the palpebral fissure in patients with thyroid-related disfunction before and after application of botulinum toxin].
Costa PG; Saraiva FP; Matayoshi S
Arq Bras Endocrinol Metabol; 2006 Oct; 50(5):920-5. PubMed ID: 17160217
[TBL] [Abstract][Full Text] [Related]
10. Botulinum toxin type a for dysthyroid upper eyelid retraction.
Morgenstern KE; Evanchan J; Foster JA; Cahill KV; Burns JA; Holck DE; Perry JD; Wulc AE
Ophthalmic Plast Reconstr Surg; 2004 May; 20(3):181-5. PubMed ID: 15167723
[TBL] [Abstract][Full Text] [Related]
11. Treatment of upper eyelid retraction associated with thyroid eye disease with subconjunctival botulinum toxin injection.
Uddin JM; Davies PD
Ophthalmology; 2002 Jun; 109(6):1183-7. PubMed ID: 12045064
[TBL] [Abstract][Full Text] [Related]
12. Peri-levator palpebrae superioris triamcinolone injection for the treatment of thyroid eye disease-associated upper eyelid retraction.
Joos ZP; Sullivan TJ
Clin Exp Ophthalmol; 2017 Aug; 45(6):651-652. PubMed ID: 28248444
[No Abstract] [Full Text] [Related]
13. Chemodenervation in treatment of upper eyelid retraction.
Ozkan SB; Can D; Söylev MF; Arsan AK; Duman S
Ophthalmologica; 1997; 211(6):387-90. PubMed ID: 9380360
[TBL] [Abstract][Full Text] [Related]
14. [Morphometric analysis of eyelid fissure in patients with eyelid retraction in acute stage of dysthyroid orbitopathy after treatment with botulinum toxin type A].
Costa PG; Saraiva FP; Pereira IC; Matayoshi S
Arq Bras Oftalmol; 2008; 71(4):480-5. PubMed ID: 18797654
[TBL] [Abstract][Full Text] [Related]
15. Hyaluronic acid gel injection for upper eyelid retraction in thyroid eye disease: functional and dynamic high-resolution ultrasound evaluation.
Kohn JC; Rootman DB; Liu W; Goh AS; Hwang CJ; Goldberg RA
Ophthalmic Plast Reconstr Surg; 2014; 30(5):400-4. PubMed ID: 24833450
[TBL] [Abstract][Full Text] [Related]
16. [Botulinum toxin treatment for crocodile tears, spastic entropion and for dysthyroid upper eyelid retraction].
Wabbels B; Förl M
Ophthalmologe; 2007 Sep; 104(9):771-6. PubMed ID: 17823804
[TBL] [Abstract][Full Text] [Related]
17. Botulinum Toxin Type A Injection for Correction of Upper Eyelid Retraction in Thyroid-Associated Ophthalmopathy.
Yang J; Hu X; Li Q; Huang RL
J Craniofac Surg; 2023 Jul-Aug 01; 34(5):e485-e488. PubMed ID: 37221639
[TBL] [Abstract][Full Text] [Related]
18. Botulinum toxin type A in upper lid retraction of Graves' ophthalmopathy.
Ebner R
J Clin Neuroophthalmol; 1993 Dec; 13(4):258-61. PubMed ID: 8113438
[TBL] [Abstract][Full Text] [Related]
19. [Two surgical methods to modify upper eyelid retraction with thyroid associated-ophthalmopathy].
Dai XQ; Ye MX
Zhonghua Zheng Xing Wai Ke Za Zhi; 2006 Sep; 22(5):358-61. PubMed ID: 17144453
[TBL] [Abstract][Full Text] [Related]
20. Repeated triamcinolone acetonide injection in the treatment of upper-lid retraction in patients with thyroid-associated ophthalmopathy.
Xu D; Liu Y; Xu H; Li H
Can J Ophthalmol; 2012 Feb; 47(1):34-41. PubMed ID: 22333849
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
